Abstract Cellular eicosapentaenoic acid (EPA) makes up approximately 3% of total fatty acids in Escherichia coli DH5a, a strain that carries EPA biosynthesis genes (pEPAD1). EPA was increased to 12% of total fatty acids when the host cell co-expressed the vector pGBM3::sa1 (vktA), which carried the high-performance catalase gene, vktA. Where this vector was co-expressed, the transformant accumulated a large amount of VktA protein. However, the EPA production of cells carrying the vector, that included the insert lacking almost the entire vktA gene, was approximately 6%. This suggests that the retention of a large DNA insert in the vector and the accumulation of the resulting protein, but not the catalytic activity of VktA catalase, would potentially be able to increase the content of EPA.
Introduction
Bacteria that are able to produce eicosapentaenoic acid (EPA) or docosahexaenoic acid (DHA) are potential sources of n-3 long chain polyunsaturated fatty acids (LC-PUFAs) for commercial use. In bacteria, EPA and DHA are synthesized de novo by polyunsaturated fatty acid synthase pfa genes following the polyketide biosynthesis pathway (Metz et al. 2001; Orikasa et al. 2004; , rather than by chain elongation and oxygen-dependent desaturation of existing fatty acids. The bacterial polyketide biosynthesis pathway has some benefits for the production of n-3 LC-PUFAs compared with the fatty acid elongation and desaturation processes, which are summarized in some reviews (Ratledge 2004; Bergé and Barnathan 2005; Okuyama et al. 2007 ).
Various techniques have been presented in order to enhance metabolically the production of n-3 LC-PUFAs by bacteria that inherently synthesize them and by host bacteria transformed with pfa genes. The production of EPA and DHA in Shewanella marinintestina IK-1 and Moritella marina MP-1, respectively, was significantly enhanced by the addition of cerulenin (Morita et al. 2005) , an inhibitor of the de novo biosynthesis of fatty acids (up to C18 fatty acids). A similar result was obtained using an EPA-producing deep-sea bacterium, Photobacterium profundum SS9 (Allen et al. 1999) . The enhancement of EPA production was also reported by Shewanella baltica that had been mutated with transposon Tn5 (Amiri-Jami et al. 2006) .
EPA (and probably DHA) reduces the antioxidative stress caused by exogenously added hydrogen peroxide (H 2 O 2 ) (Nishida et al. 2006a, b) . These results suggest that there might be some physiological relationship between EPA and H 2 O 2 (oxidative stresses), or between EPA and H 2 O 2 -decomposing reactions. In the present study, the enhanced production of EPA was observed in recombinant systems consisting of E. coli that carried both EPA biosynthesis genes and a 4.9 kbp fragment of foreign DNA that included the 1.5 kbp high-performance catalase gene, vktA . Although no molecular mechanism has been determined for this enhanced production of EPA, this technique may become another useful method to increase the productivity of LC-PUFAs using recombinant systems.
Materials and methods

Bacterial strains and culture conditions
Escherichia coli strain DH5a (Takara Bio, Kyoto, Japan) was used throughout the work. LuriaBertani medium supplemented with 50 lg ampicillin ml -1 was used for the culture of E. coli DH5a cells that had been transformed with the EPA biosynthesis pfa genes (pEPAD1). Cultivation was carried out on a shaker (180 rpm) at 20°C for 30-40 h. Cells carrying pGBM3 (Manen et al. 1997) , pKT230 (Bagdasarian et al. 1981) The pEPAD1 is a cosmid vector that carries a 35 kbp DNA fragment including all five genes necessary for the production of EPA (pfaA, pfaB, pfaC, pfaD, and pfaE) (Orikasa et al. 2004; .
The high-performance catalase gene, pBSsa1 was used. pBSsa1 is a derivative of pBluescript II SK+ that includes a vktAcontaining DNA fragment, sa1 [presented as sa1(vktA) in this study], consisting of 4904 bp cloned from the H 2 O 2 -resistant bacterium Vibrio rumoiensis S-1 (Yumoto et al. 1999) . The restriction maps of pGBM3 vector and inserts are shown in Fig. 1 .
The gene, pBSsa1, was treated with XhoI and BamHI, and the resulting sa1(vktA)-containing fragment was integrated into the XhoI-BamHI site of pBBR1MCS-2 (5144 bp) (Kovach et al. 1995) . The constructed vector, pBBR1MCS-2::sa1(vktA), was digested with BamHI and XhoI, and the insert fragment, sa1(vktA), was ligated into the plasmids pGBM3 and pKT230, which had been digested with the same restriction enzymes. The resulting clones were designated pGBM3::sa1(vktA) and pKT230::sa1(vktA).
To generate a clone without vktA, pBBR1MCS::sa1(vktA) was constructed by integrating the XhoI and BamHI-containing fragment from pBSsa1 into pBBR1MCS (Kovach et al. 1994 ). Vector pBBR1MCS::sa1(vktA) was digested with PstI to remove the 1594 bp region (between two PstI sites), including most of vktA and a partial sequence (51 bp) derived from pBluescript II SK+. The pBBR1MCS vector from which vktA had been removed [pBBR1MCS:: sa1(DvktA)] was joined into a circle. Vector pBBR1MCS::sa1(DvktA) was digested with XhoI and BamHI, and the vktA-deleted sa1 clone (from XhoI to BamHI; 3.4 kbp) was integrated into the XhoI-BamHI sites of pGBM3. The resulting vector was designated pGBM3::sa1(DvktA). The sa1(DvktA) clone included all the sequence upstream from the ATG initiation codon of vktA, and only a remnant of vktA from the initiation codon to the 85th nucleotide of vktA (the PstI site; see Fig. 1B ) remained. This was followed by the 16-nucleotide sequence derived from pBluescript II SK+. When pBBR1MCS:: sa1(DvktA) was treated with PstI and SalI, no vktA gene was detected using gel electrophoresis (data not shown). Escherichia coli JM109 transformed with pBBR1MCS::sa1(DvktA) had only base levels of catalase activity (data not shown).
Determination of catalase activity, SDS-PAGE and GLC
Catalase activity was measured spectrophotometrically using cell-free extracts by monitoring the decrease in absorbance at 240 nm resulting from the elimination of H 2 O 2 . The enzyme activity unit (U) was defined as the amount of enzyme activity that decomposed 1 lmol H 2 O 2 min -1 . SDS-PAGE of cell-free extracts was carried out as described previously . Protein was estimated by the Bradford method using bovine serum albumin as a standard.
Fatty acids were analyzed as their methyl esters by GLC as described previously .
Results and discussion
Growth of E. coli DH5a transformants
Escherichia coli DH5a transformants carrying pEPAD1, pEPAD1 plus pGBM3, and pEPAD1 plus pGBM3::sa1(vktA) were designated DH5a (pEPAD1), DH5a(pEPAD1)(pGBM3), and DH5 a(pEPAD1)[pGBM3::sa1(vktA)], respectively. Escherichia coli DH5a cells carrying pEPAD1 plus pKT230 and pEPAD1 plus pKT230::sa1 (vktA) were similarly named. The E. coli DH5a transformant carrying pEPAD1 plus pGBM3::sa1(DvktA) was named DH5a(pEPAD1) [pGBM3::sa1(DvktA)].
Escherichia coli DH5a carrying no vector needed approximately 30 h to reach the late log phase of growth (an OD 660 of approximately 1) at 20°C (Fig. 2) . Transformation with pEPAD1 or pEPAD1 plus another vector delayed the growth of the transformants by 2-10 h. Generally, transformants carrying pGBM3 with a larger insert grew more slowly. Approximately 40 h was needed for DH5a(pEPAD1)[pGBM3::sa1(vktA)] to reach an OD 660 of 1. Introduction of pEPAD1 to the host cell led to the production of EPA (approximately 3% of total fatty acids; Table 1 ). The production of EPA in host organisms carrying pEPAD1 was increased to 12% of total fatty acids by the introduction of the sa1(vktA) insert that included the highperformance catalase gene, vktA, in pGBM3. The empty pGBM3 had no effect on EPA production. In DH5a(pEPAD1)[pGBM3::sa1 (DvktA)], EPA made up 6% of total fatty acids. The increase in EPA production in DH5a (pEPAD1)[pGBM3::sa1(vktA)] was accompanied by a decrease in the proportions of palmitoleic acid [16:1(9)] (Table 1) . When pGBM3 and pGBM3::sa1(vktA) were replaced in the E. coli transformants with pKT230 and pKT230::sa1(vktA), respectively, similar trends were observed (data not shown).
The yield of EPA per culture was approximately 1.5 lg ml -1 for DH5a(pEPAD1) and DH5a(pEPAD1)(pGBM3). It increased to 7.3 lg ml -1 for DH5a(pEPAD1)[pGBM3::sa1(vktA)]. The yield of EPA from DH5a(pEPAD1) [pGBM3::sa1(DvktA)] was 3.3 lg ml -1 (Table 1) .
Catalase activity and catalase protein accumulation in E coli DH5a transformants
Escherichia coli DH5a has an inherent catalase activity of 2-3 U mg protein -1 ). The plasmid pEPAD1 had no effect on the catalase activity of the host cells. Catalase activity was increased to 535 U mg protein -1 for DH5a(pEPAD1)[pGBM3::sa1(vktA)]. However, there was no enhancement of catalase activity in DH5a(pEPAD1)[pGBM3::sa1(DvktA)] (Table 2) . Figure 3 shows the profiles of proteins prepared from various E. coli DH5a transformants using SDS-PAGE. A significant amount of protein in the VktA band, i.e., 57 kDa, was detected only for DH5a(pEPAD1)[pGBM3::sa1(vktA)]. No notable novel band was observed in DH5a (pEPAD1)[pGBM3::sa1(DvktA) or in any of the other transformants.
It is evident that bacterial EPA or DHA is synthesized by the polyketide biosynthesis pathway (Metz et al. 2001; Orikasa et al. 2006b) , and that this process operates independently of the Fig. 2 Growth profiles of Escherichia coli DH5a and its various transformants at 20°C. s, E. coli DH5a carrying no vector; d, E. coli DH5a carrying pEPAD1; m E. coli DH5a carrying pEPAD1 plus empty pGBM3; n, E. coli DH5a carrying pEPAD1 plus pGBM3::sa1(vktA); h, E. coli DH5a carrying pEPAD1 plus pGBM3::sa1(DvktA) E. coli DH5a 36.0 ± 1.0 29.6 ± 0.7 22.0 ± 0.6 0 12.5 ± 1.4 0 E. coli DH5a(pEPA (1) 35.6 ± 0.9 26.9 ± 1.5 21.8 ± 0.9 2.5 ± 0.2 13.2 ± 2.7 1.7 ± 0.1 E. coli DH5a(pEPA (1)(pGBM3) 38.6 ± 1.8 28.2 ± 0.6 20.8 ± 0.3 3.2 ± 1.7 9.2 ± 1.1 1.5 ± 1.3 E. coli DH5a(pEPA(1)[pGBM3::sa1(vktA)] 35.9 ± 3.1 18.5 ± 0.4 22.9 ± 1.9 12.3 ± 0.7 10.3 ± 0.8 7.3 ± 1.2 E. coli DH5a(pEPA(1)[pGBM3::sa1(vktA)] 34.0 ± 0.7 26.7 ± 0.2 24.1 ± 1.2 5.9 ± 0.2 9.2 ± 1.7 3.3 ± 0. de novo biosynthesis of fatty acids up to C16 or C18 (Metz et al. 2001; Morita et al. 2000) . However, it is likely that acetyl-CoA would be commonly used as a priming substrate in both processes, as specific inhibition of the de novo synthesis of fatty acids up to C18 by cerulenin enhanced the production of EPA and DHA in bacteria (Allen and Bartlett 2002; Morita et al. 2005) and probably also in Schizochytorium (Hauvermale et al. 2006) . This is analogous to the situation in the unsaturated fatty acid auxotroph E. coli fabB -that was transformed with bacterial pfa genes, where EPA accounted for more than 30% of total fatty acids (Metz et al. 2001; Valentine and Valentine 2004) . All of these findings suggest that the metabolic regulation of host organisms carrying pfa genes responsible for EPA or DHA biosynthesis could potentially be used commercially to enhance the production of these LC-PUFAs.
In this study, the enhanced production of EPA in E. coli DH5a expressing pEPAD1 has been achieved by introducing another 4.9 kbp foreign DNA fragment [sa1 (vktA) ] that included the high-performance catalase gene, vktA (ORF a, Fig. 1B) . The VktA belongs to the bacterial clade 3 catalase (Ichise 2003; Chelikani et al. 2004 ) and was cloned from V. rumoiensis S-1, a strain with an extraordinarily high catalase activity . This bacterium accumulates high levels of VktA protein, of which amount is calculated approximately 2% of total soluble proteins . As well as V. rumoiensis S-1, a significant accumulation of VktA was observed in DH5a(pE-PAD1)[pGBM3::sa1(vktA)] (Fig. 3) . However, the fact that a slight increase in EPA production was also observed in DH5a(pEPAD1)[pGBM3::-sa1(DvktA)]excludes the possibility that the catalytic activity of VktA protein per se was involved in this increased EPA production. Although the sa1(vktA) DNA fragment includes one other open reading frame (ORF b) in addition to the vktA gene (Fig. 1B) , protein product from this ORF would not increase the production of EPA as the ORF b remains in the sa1(DvktA) fragment. a Cells were washed three times with phosphate buffer (pH 7.5) by centrifugation at 3,000 · g for 15 min, and they were then suspended in 0.2 ml of 60 mM potassium phosphate buffer (pH 7.0). Cells were disrupted by sonic oscillation using a Sonifier Cell Disruptor (model W185; Branson Ultrasonic Corp., Danbury, CT) for 40 s in an ice bath. Supernatants were removed after the centrifugation of cell lysates at 20,000 · g for 60 min and were used as cell-free extracts At present, the mechanism for the enhanced production of EPA in E. coli recombinant systems carrying DH5a(pEPAD1)[pGBM3:: sa1(vktA)] (Table 1) and DH5a(pEPAD1) [pKT230::sa1(vktA)] (data not shown) is unknown. One possibility is that the increase in production of EPA is a response against intracellular stress. The growth of E. coli DH5a recombinants was delayed (Fig. 2) , which would be due to their retention of the second vector, pGBM3, or its derivatives. The size of the insert was 0 bp (4066 bp as vector), 4955 bp (9021 bp), and 3361 bp (7427 bp) for pGBM3, pGBM3::sa1(vktA), and pGBM3::sa1(DvktA), respectively. The slowing of growth was positively correlated with the size of the pGBM3 insert (Fig. 2) . Additionally, DH5a(pE-PAD1)[pGBM3::sa1(vktA)] accumulated a large amount of VktA protein, which may have increased the stress for the host cell. This would have delayed their growth.
Recently, Nishida et al. (2006a; provided evidence that cellular EPA has an antioxidative function against extracellular H 2 O 2 in bacterial recombinant systems expressing EPA biosynthesis (pfa) genes. Interestingly, levels of protein carbonyls were much lower in E. coli carrying pfa genes (with EPA) than in E. coli carrying no vector (without EPA), even if they were not treated with H 2 O 2 . That is, cellular EPA may exert an antioxidative effect on reactive oxygen species produced intracellularly . A variety of stressful conditions, such as heat shock, osmotic shock, nutrient deprivation, and oxidative stress, are known to induce the synthesis of specific proteins. In E. coli, the induction of a protein was elicited in response to the overexpression of foreign proteins (Arora and Pedersen 1995) . However, to our knowledge, instances where the expression of one foreign gene (DNA) induces the expression of another foreign gene(s) have never been reported. Clarification of the mechanism of increased EPA (and probably DHA) biosynthesis and the combined use of this technique with others described above would provide the possibility of greater production of these useful polyunsaturated fatty acids.
